PHASE-II TRIAL OF 1,2-DIAMINOCYCLOHEXANE-(4-CARBOXYPHTHALATO) PLATINUM(II) IN PATIENTS WITH REFRACTORY GERM-CELL TUMORS

被引：0
|
作者：
CHUN, H [1 ]
BOSL, GJ [1 ]
GOLBEY, RB [1 ]
机构：
[1] CORNELL UNIV,MED CTR,COLL MED,DEPT MED,NEW YORK,NY 10021
来源：
CANCER TREATMENT REPORTS | 1985年 / 69卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：459 / 460
页数：2
相关论文
共 50 条
  • [21] PHASE-II TRIAL OF COMBINATION CHEMOTHERAPY IN PATIENTS WITH EXTRAGONADAL GERM-CELL TUMORS - SOUTHWEST-ONCOLOGY-GROUP STUDY
    BUKOWSKI, RM
    MONTIE, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 166 - 166
  • [22] A PHASE-II TRIAL OF CIS DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM (II) (CBDCA) IN PATIENTS (PTS) WITH CISPLATIN (DDP) RESISTANT GERM-CELL TUMORS (GCT)
    MOTZER, RJ
    TAUER, K
    BOSL, GJ
    GOLBEY, RB
    YAGODA, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 188 - 188
  • [23] Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206
    Adra, N.
    Einhorn, L. H.
    Althouse, S. K.
    Ammakkanavar, N. R.
    Musapatika, D.
    Albany, C.
    Vaughn, D.
    Hanna, N. H.
    ANNALS OF ONCOLOGY, 2018, 29 (01) : 209 - 214
  • [24] Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors
    Kondagunta, GV
    Bacik, J
    Schwartz, L
    Sheinfeld, J
    Bajorin, D
    Vuky, J
    Marion, S
    Mazumdar, M
    Bosl, GJ
    Motzer, RJ
    INVESTIGATIONAL NEW DRUGS, 2004, 22 (02) : 177 - 179
  • [25] Phase II trial of pyrazoloacridine in patients with cisplatin-refractory germ cell tumors
    Vuky, J
    McCaffrey, J
    Ginsberg, M
    Mariani, T
    Bajorin, DF
    Bosl, GJ
    Motzer, RJ
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (03) : 265 - 267
  • [26] Phase II Trial of ixabepilone in patients with cisplatin-refractory germ cell tumors
    Feldman, Darren R.
    Kondagunta, G. Varuni
    Ginsberg, Michelle S.
    Ishill, Nicole
    Patil, Sujata
    Cestaro, John
    Obbens, Eugenie
    Sheinfeld, Joel
    Bosl, George J.
    Motzer, Robert J.
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (05) : 487 - 490
  • [27] Phase II Trial of Temozolomide in Patients with Cisplatin-Refractory Germ Cell Tumors
    G. Varuni Kondagunta
    Jennifer Bacik
    Lawrence Schwartz
    Joel Sheinfeld
    Dean Bajorin
    Jacqueline Vuky
    Stephanie Marion
    Madhu Mazumdar
    George J. Bosl
    Robert J. Motzer
    Investigational New Drugs, 2004, 22 : 177 - 179
  • [28] Phase II Trial of ixabepilone in patients with cisplatin-refractory germ cell tumors
    Darren R. Feldman
    G. Varuni Kondagunta
    Michelle S. Ginsberg
    Nicole Ishill
    Sujata Patil
    John Cestaro
    Eugenie Obbens
    Joel Sheinfeld
    George J. Bosl
    Robert J. Motzer
    Investigational New Drugs, 2007, 25 : 487 - 490
  • [29] Phase II Trial of Pyrazoloacridine in Patients with Cisplatin-Refractory Germ Cell Tumors
    Jacqueline Vuky
    John McCaffrey
    Michelle Ginsberg
    Tania Mariani
    Dean F. Bajorin
    George J. Bosl
    Robert J. Motzer
    Investigational New Drugs, 2000, 18 : 265 - 267
  • [30] PHASE-II TRIAL OF 13CIS RETINOIC ACID IN THE TREATMENT OF PATIENTS (PTS) WITH ADVANCED GERM-CELL TUMORS (GCT)
    GOLD, E
    BOSL, GJ
    WHITMORE, W
    MYERS, WPL
    GOLBEY, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 150 - 150
12345